首页> 外文期刊>American journal of medical genetics, Part A >Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS)
【24h】

Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS)

机译:患有和不患有脆性X相关震颤/共济失调综合征(FXTAS)的FMR1突变男性的高血压

获取原文
获取原文并翻译 | 示例
           

摘要

Fragile X-associated tremor ataxia syndrome (FXTAS) is a late onset neurodegenerative disease that affects carriers of the fragile X premutation. This study seeks to assess hypertension risk and susceptibility in male premutation carriers with FXTAS. Although many symptoms and diagnostic criteria have been identified, hypertension risk has not been examined in this population. Data from 92 premutation carriers without FXTAS, 100 premutation carriers with FXTAS, and 186 controls was collected via patient medical interview. Age-adjusted logistic regression analysis was used to examine the relative odds of hypertension. We observed a significantly elevated odds ratio (OR) of hypertension relative to controls for premutation carriers with FXTAS (OR=3.22, 95% CI: 1.72-6.04; P=0.0003) among participants over 40-year old. The age-adjusted estimated odds of hypertension in premutation carriers without FXTAS in the over 40-year-old age group was higher compared to controls (OR=1.61, 95% CI: 0.82-3.16), but was not statistically significant (P=0.164). Chronic hypertension contributes to cardiovascular complications, dementia, and increased risk of stroke. Our results indicate that the risk of hypertension is significantly elevated in male premutation carriers with FXTAS compared with carriers without FXTAS and controls. Thus, evaluation of hypertension in patients diagnosed with FXTAS should be a routine part of the treatment monitoring and intervention for this disease.
机译:脆性X相关震颤共济失调综合征(FXTAS)是一种迟发性神经退行性疾病,会影响脆性X预突变的携带者。这项研究旨在评估使用FXTAS的男性突变前携带者的高血压风险和易感性。尽管已鉴定出许多症状和诊断标准,但尚未对该人群进行高血压风险检查。通过患者医学访谈收集了来自不带FXTAS的92个预突变载体,带FXTAS的100个预突变载体和186个对照的数据。年龄调整后的逻辑回归分析用于检查高血压的相对几率。我们观察到,相对于40岁以上参与者中带有FXTAS的突变前携带者的对照,高血压的优势比(OR)显着提高(OR = 3.22,95%CI:1.72-6.04; P = 0.0003)。 40岁以上年龄组中没有FXTAS的突变前携带者的年龄调整后估计高血压几率高于对照组(OR = 1.61,95%CI:0.82-3.16),但无统计学意义(P = 0.164)。慢性高血压会导致心血管并发症,痴呆和中风风险增加。我们的结果表明,与没有FXTAS和对照的携带者相比,具有FXTAS的男性变异携带者的高血压风险显着增加。因此,对诊断为FXTAS的患者进行高血压评估应该是对该疾病进行治疗监测和干预的常规步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号